1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Swiss MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder (PTSD)

Swiss MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder (PTSD)

  1. ZenobiaSky
    MAPS-Sponsored Clinical Trials: MDMA-Assisted Psychotherapy for PTSD

    MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder (PTSD)
    Principal Investigator: Peter Oehen, MD, with co-therapist Verena Widmer, RN
    Location: Solothurn, Switzerland

    Published in the Journal of Psychopharmacology October 31, 2012

    Our Swiss MDMA/PTSD pilot study had full approval from an Ethics Committee (Swiss IRB equivalent) and SwissMedic (FDA equivalent). The protocol had also been submitted to, and accepted by, the FDA under MAPS’ Investigational New Drug (IND) application for MDMA. The study is a part of MAPS’ clinical plan to develop MDMA into a prescription medicine approved by both the FDA and the European Medicines’ Agency (EMEA).